|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1998-2-5
|
|
pubmed:abstractText |
A comparative evaluation of the following commercial immunoassays for the determination of antibodies to Toxoplasma gondii was performed: Behring Diagnostics OPUS Toxo G and Toxo M, Abbott Diagnostics IMX Toxo-IgG 2.0 and Toxo-IgM, Sanofi Diagnostics Pasteur Platelia Toxo IgG and Toxo IgM, and bioMérieux Vitek VIDAS Toxo IgG and IgM. Of 676 specimens that were tested for Toxoplasma-specific immunoglobulin G (IgG) antibodies, 26% were reactive by all methods while 8% displayed some discrepancy. Of 718 specimens that were tested for Toxoplasma-specific IgM antibodies, 3% were reactive by all methods while 10% displayed some discrepancy. Analysis of discrepant specimens revealed performance shortcomings with all IgM-specific assays. The impact of such shortcomings is magnified in a population with a low prevalence of toxoplasmosis.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-1424515,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-1624595,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-1757547,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-1763842,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-17744024,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-7031082,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-7709628,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-8641303,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-8831053,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-8880514,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-8922828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9399544-8968902
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0095-1137
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3313-5
|
|
pubmed:dateRevised |
2010-9-10
|
|
pubmed:meshHeading |
pubmed-meshheading:9399544-Animals,
pubmed-meshheading:9399544-Antibodies, Protozoan,
pubmed-meshheading:9399544-Evaluation Studies as Topic,
pubmed-meshheading:9399544-Humans,
pubmed-meshheading:9399544-Immunoassay,
pubmed-meshheading:9399544-Immunoglobulin G,
pubmed-meshheading:9399544-Immunoglobulin M,
pubmed-meshheading:9399544-Parasitology,
pubmed-meshheading:9399544-Predictive Value of Tests,
pubmed-meshheading:9399544-Sensitivity and Specificity,
pubmed-meshheading:9399544-Toxoplasma,
pubmed-meshheading:9399544-Toxoplasmosis
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems.
|
|
pubmed:affiliation |
Department of Laboratory Medicine, University of Washington, Seattle, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
